(Q35202142)

7 August 2017

1 reference

title

Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view (English)

1 reference

7 August 2017

1 reference

Zimmet P

1

1 reference

PubMed ID

12925046

7 August 2017

Shaw J

series ordinal

2

1 reference

PubMed ID

12925046

7 August 2017

Alberti KG

series ordinal

3

1 reference

7 August 2017

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

20

1 reference

7 August 2017

9

1 reference

7 August 2017

693-702

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Marked Improvement in Carbohydrate and Lipid Metabolism in Diabetic Australian Aborigines After Temporary Reversion to Traditional Lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Diabetes epidemiology as a tool to trigger diabetes research and care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Emerging epidemic of type 2 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

THE PREVENTION OF DIABETES MELLITUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Decreasing prevalence of cigarette smoking in the middle income country of Mauritius: questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

The prevention or delay of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01052.X

10.1046/J.1464-5491.2003.01052.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12925046